(Q35099075)

6 August 2017

1 reference

title

Transition of care between paediatric and adult gastroenterology. Cystic fibrosis (English)

1 reference

6 August 2017

0 references

1 reference

Reuben Jackson

1

1 reference

6 August 2017

Paul B Pencharz

series ordinal

2

1 reference

6 August 2017

language of work or name

1 reference

1 April 2003

1 reference

Best Practice and Research: Clinical Gastroenterology

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

213-235

1 reference

CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Effects of nutritional status on exercise performance in advanced cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Treatment of cystic fibrosis in the adult

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Novel pharmacologic therapies for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

The diagnosis of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Nutritional management of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Pathogenesis of malnutrition in cystic fibrosis, and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Hypoalbuminemia at initial examination in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Hypoproteinemia, anemia, and failure to thrive in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Hemolytic anemia and edema as the initial signs in infants with cystic fibrosis. Consider this diagnosis even in absence of pulmonary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Anaemia, vitamin E deficiency and failure to thrive in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Persistent morbidity and mortality of protein calorie malnutrition in young infants with CF

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Nutrition and cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Nutrition intervention for weight gain in cystic fibrosis: a meta analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Eating disorders in adolescents with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and season

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Prevalence of vitamin K deficiency in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Pancreatitis in young children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Meconium ileus in the absence of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Treatment of uncomplicated meconium ileus by Gastrografin enema: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

T-tube ileostomy for meconium ileus: four decades of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Clinical course of patients with cystic fibrosis presenting with meconium ileus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Long-term outcome after neonatal meconium obstruction.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Crohn's disease in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Crohn's disease and cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Cholangiocyte biology and cystic fibrosis liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Liver disease and common-bile-duct stenosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Neonatal cholestasis as the presenting feature in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Natural history of liver disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Gallstones in cystic fibrosis: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Glucose intolerance with low-, medium-, and high-carbohydrate formulas during nighttime enteral feedings in cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Transplantation for cystic fibrosis: outcome following early liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Assessment of survival benefit after lung transplantation by patient diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

The Risk of Cancer among Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Transition programs in cystic fibrosis centers: perceptions of pediatric and adult program directors.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Burkholderia cepacia in cystic fibrosis. Variable disease course.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Survival of Burkholderia cepacia on environmental surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Fertility in Men With Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Impact of lactation on women with cystic fibrosis and their infants: a review of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

Transition from paediatric to adult care for persons with cystic fibrosis: patient and parent perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2802%2900150-6

7 January 2021

10.1016/S1521-6918(02)00150-6

Identifiers

DOI

1 reference

6 August 2017

1 reference